February 12, 2014

Indian firms need to focus on IP-led growth: KPMG

  OUR LATEST ON TWITTER

Global Innovation Policy Center @globalIPcenter 1h

“Undermining #IP rights for vaccines will not accelerate global production, instead it will take us off track in the ongoing, successful efforts to license and scale global production of vaccines that individuals can be confident are safe and effective.” https://t.co/LM6P5k6I29

Reply Retweet Favorite


Subscribe for updates from GIPC